Co-presence of Epstein-Barr virus and high-risk human papillomaviruses in Syrian colorectal cancer samples

Hum Vaccin Immunother. 2020 Oct 2;16(10):2403-2407. doi: 10.1080/21645515.2020.1726680. Epub 2020 Mar 18.

Abstract

We recently performed two studies exploring the presence of Epstein-Barr virus (EBV) and high-risk human papillomaviruses (HPVs) types 16, 18, 31, 33 and 35 in human colorectal cancers from the Syrian population. Herein, we report that EBV and high-risk HPVs are co-present in colorectal cancers from Syria. We reveal that 17 (~17%) of 102 cancer samples are positive for both EBV and high-risk HPVs and their co-presence is associated with high/intermediate grade invasive carcinomas. These data suggest that EBV and high-risk HPVs are co-present in human colorectal cancers where they might cooperate on the initiation and/or progression of these cancers. Thus, we believe that future studies are necessary to confirm the co-presence of these oncoviruses and their cooperative role in human colorectal carcinogenesis.

Keywords: EBV; Syrian population; cancer phenotype; colorectal cancer; high-risk HPV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alphapapillomavirus*
  • Colorectal Neoplasms*
  • Epstein-Barr Virus Infections* / complications
  • Epstein-Barr Virus Infections* / epidemiology
  • Herpesvirus 4, Human
  • Humans
  • Papillomavirus Infections* / complications
  • Papillomavirus Infections* / epidemiology
  • Syria / epidemiology

Grants and funding

This work was supported by grants from Qatar University: QUHI-CMED-19/20-1 and GCC # 2017-002 QU/KU.